NCT04397016|Completed
Cost Talk: Discussing Cancer Care Costs
Cost Talk: a Randomized Stepped Wedge Trial of Interventions Helping Patients Discuss Cancer Care Costs With Clinicians During Shared Decision Making
Loading search results
Cost Talk: a Randomized Stepped Wedge Trial of Interventions Helping Patients Discuss Cancer Care Costs With Clinicians During Shared Decision Making
Sponsor study identifier
interventional
117
1 country
1
Study Start
June 12, 2020
Actual (reported)Primary Completion
April 20, 2022
Actual (reported)Study Completion
July 2, 2022
Actual (reported)The purpose of this study is to investigate whether an encounter decision aid (used during a consultation) containing cost information about options, combined with clinician training about cost discussions and available financial resources, influence surgeon-patient cost conversations, referrals to address costs, patients' financial stress, and high-quality decision-making for patients with slow-growing prostate cancer.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 2, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
May 11, 2020
Actual (reported)May 21, 2020
Actual (reported)June 12, 2020
Actual (reported)April 20, 2022
Actual (reported)July 2, 2022
Actual (reported)Frequency of cost conversations
Immediately after the clinic or virtual visit
Initiator (surgeon, patient, or caregiver) of cost conversations
Immediately after the clinic or virtual visit
Whether or not a referral is made to address costs
Immediately after the clinic or virtual visit
Number of patients who had a decisional conflict
Immediately after the clinic or virtual visit
Number of patients who engaged in high-quality shared decision-making - CollaboRATE
Immediately after the clinic or virtual visit
Decision regret
3 month follow-up
Number of patients who had a decisional conflict
3 month follow-up
Financial toxicity
3 month follow-up
* Each participating urologic surgeon will begin in the usual care arm of the study. Subsequently, they will be randomized to the intervention arm at staggered time points to undergo training and begin using the Option Grid decision aid intervention with patients who are diagnosed with slow-growing prostate cancer. * Usual Care-Participating clinicians have treatment options discussion with patients with slow-growing prostate cancer. Visits are audio-recorded and/or described by patient self-report measure.
* Each participating urologic surgeon will begin in the usual care arm of the study. Subsequently, they will be randomized to the intervention arm at staggered time points to undergo training and begin using the Option Grid decision aid intervention with patients who are diagnosed with slow-growing prostate cancer. * Decision Aid-Participating surgeons use an encounter decision aid to discuss treatment options with patients who have slow-growing prostate cancer. Visits are audio-recorded and/or evaluated by patient self-report measure.
-A table with side-by-side comparisons of treatment options organized as responses to patients' frequently asked questions
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Washington University School of Medicine
St Louis, Missouri, 63110, United States
Politi MC, Forcino RC, Parrish K, Durand MA, O'Malley AJ, Moses R, Cooksey K, Elwyn G. The impact of adding cost information to a conversation aid to support shared decision making about low-risk prostate cancer treatment: Results of a stepped-wedge cluster randomised trial. Health Expect. 2023 Oct;26(5):2023-2039. doi: 10.1111/hex.13810. Epub 2023 Jul 2.
Politi MC, Forcino RC, Parrish K, Durand MA, O'Malley AJ, Elwyn G. Cost talk: protocol for a stepped-wedge cluster randomized trial of an intervention helping patients and urologic surgeons discuss costs of care for slow-growing prostate cancer during shared decision-making. Trials. 2021 Jun 29;22(1):422. doi: 10.1186/s13063-021-05369-4.
Mary Politi, Ph.D.
Washington University School of Medicine
Glyn Elwyn, M.D., Ph.D., MSc
Dartmouth College
117 participants (actual enrollment reported by the registry).
First Submitted
May 11, 2020
Contact the study team to confirm eligibility.
First Posted
May 21, 2020
Study Start
June 12, 2020
Actual (reported)Primary Completion
April 20, 2022
Actual (reported)Study Completion
July 2, 2022
Actual (reported)Last Updated
September 26, 2022
Record last verified: 2022-09
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: